Enzo Biochem Doubles Capacity for COVID-19 Testing
Enzo Biochem reports that it has expanded reagent and supply manufacturing as well as doubled its capacity for molecular lab testing services at its facilities in Farmingdale, NY to meet the increasing demand for...
Exicure, Inc. to Present at the BTIG Virtual Biotechnology Conference – Business Wire
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc.® (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today announced that CEO David Giljohann will present at the BTIG Virtual...
Novel Cell Analysis Tool Bridges In Situ Microscopy and Single Cell Omics
Scientists have developed a new method that allows them to select individual cells from a population that is growing on the surface of a laboratory dish, and then study their contents using DNA and...
Partners in crime: genetic collaborator may influence severity of the rare disease, NGLY1
Credit: Photo credit: Charlie Ehlert/University of Utah Health
In 2012, four-year-old Bertrand Might became the first-ever patient diagnosed with a rare genetic disorder called N-glycanase (NGLY1) deficiency....
Curative Biotechnology, Inc. Announces FINRA Ticker Symbol Change From CTYX To CUBT – BioSpace
BOCA RATON, Fla., April 29, 2021 /PRNewswire/ -- Curative Biotechnology, Inc. (OTC: CUBT) a development stage biomedical company focused on novel therapies for rare diseases, announced today the Company's trading symbol change from "CTYX" to...
The global agricultural biotechnology market revenue from – GlobeNewswire
New York, May 26, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Agricultural Biotechnology Market" - https://www.reportlinker.com/p06075982/?utm_source=GNW From 7.7 billion in 2019, the global population will reach 11.2 billion by 2100,...
FDA approves investigational monoclonal antibody therapy sotrovimab for COVID-19
The U.S. Food and Drug Administration (FDA) has given the green light on the investigational monoclonal antibody therapy, sotrovimab, as a treatment for coronavirus disease 2019 (COVID-19). The regulatory agency granted an Emergency Use...
BGI discovery could pave the way for advances in organ regeneration and synthetic biology
In a world-first, scientists from BGI-Research, Chinese Academy of Sciences, and a group of partners published a study in Nature, announcing the discovery of a transgene-free, rapid, and controllable method to convert pluripotent stem-cells...
Staten Biotechnology, in collaboration with Novo Nordisk, starts dosing of anti-apoC3 antibody SST-5058 in...
NIJMEGEN, The Netherlands--(BUSINESS WIRE)--Staten Biotechnology B.V. announced today the initiation of dosing of the Company’s lead asset, STT-5058, in a First-in-Human clinical study.
STT-5058 is a monoclonal antibody that targets the lipoprotein ApoC3 and...
Investors Turn to Biotechnology for a Sustainable Future – Labiotech.eu
The next industrial revolution is going to be a bio-revolution. It has to be, given that the byproducts of the original industrial revolution created the major pollution problems we now have to solve. But...
